CLONIDINE HYDROCHLORIDE TABLETS

Clonidine Hydrochloride Tablets USP, 0.1 mg strength, are procured in bottles of 100 tablets each, with a total shelf life of 24 months and a minimum of 21 months of remaining shelf life required at the time of receipt by the first government activity. The product must be stored at controlled room temperature between 20°C to 25°C (68°F to 77°F) and is designated for oral administration only. Packaging and labeling must comply with Medical Marking Standard No. 1A dated February 4, 2013, superseding all references to MIL-STD-129. Each unit must be sealed in commercial-grade containers that protect against damage and be packed in suitable exterior shipping containers to ensure safe, low-cost delivery to the destination via common carrier. The item is regulated by the FDA and classified as a TYPE I (CODE M) medical product with a non-extendable shelf life. The manufacturer is Teva Pharmaceuticals USA, Inc., with NDC 00228-2127-10. The contract calls for delivery of 10 bottles in total under solicitation SPE2DP-26-T-4056, with a required delivery date of July 10, 2026, and a 20-day delivery window. Shipments must meet all hazardous materials packaging and marking standards, and the destination includes both APO AP 96213-2166 and GWANGJU AB, Korea. The contracting office is the Department of Defense Medical Supply Chain, with James Foggie as the primary point of contact.